Rosemina Merchant
Founder at MEDICENNA THERAPEUTICS CORP.
Net worth: 7 M $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Fahar Merchant | M | - |
Intelligene Expressions, Inc.
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 29 years |
Jack Geltosky | M | 78 | 16 years | |
Albert Beraldo | M | - |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 8 years |
Andrew L. Strong | M | 57 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 5 years |
Karen Dawes | F | 72 | 5 years | |
Delphine Davan | F | - | 1 years | |
John Sampson | M | - | 3 years | |
Eamonn Peters | M | - | 1 years | |
David Hyman | M | - | - | |
Evelyn Pau | M | - | 1 years | |
Minh To | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Elizabeth Williams | F | - | 7 years | |
Randall E. Woods | M | 72 | - | |
Chandrakant Panchal | M | 74 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | 7 years |
Lars Ekman | M | 74 | 10 years | |
Frank Holler | M | 67 | 9 years | |
Allison Hulme | M | 61 | - | |
Leonard J. Cox | M | 52 | 2 years | |
Amit Sobti | M | 45 | 2 years | |
Peter T. Slover | M | 49 | - | |
William R. Rohn | M | 80 | 3 years | |
Nishan de Silva | M | 51 | 2 years | |
William Li | M | 61 | 2 years | |
David Swetlow | M | - | 2 years | |
Jonathan Leff | M | 55 | 2 years | |
Samuel R. Denmeade | M | - | - | |
Mark R. Brunswick | M | - | 5 years | |
Jay Stoudemire | M | - | - | |
Humphrey Gardner | M | 60 | 1 years | |
Annica Mårtensson | M | - | - | |
Patrick Ward | M | - | - | |
Martin Bexon | M | - | - | |
Mann Muhsin | M | - | 1 years | |
Brent Meadows | M | - | - | |
John Parkinson | M | - | - | |
Richard C. Yocum | M | 68 | 5 years | |
Kenneth H. Haas | M | 73 |
Intelligenetics, Inc.
Intelligenetics, Inc. Information Technology ServicesTechnology Services Intelligenetics, Inc. engages in the provision of bioinformatics services. The company is headquartered in Campbell, CA. | 9 years |
Thomas D'Orazio | M | - | - | |
Shafique Fidai | M | - | - | |
Kevin Moulder | M | - | 1 years | |
Anthony Boone | M | - | - | |
Jim J. Miller | M | 64 | 5 years | |
Kevin McDuffie | M | - | - | |
Alexander R. Giaquinto | M | 80 | 1 years | |
Trevor Wong-Chor | M | 56 | - | |
Nitin Kaushal | M | 58 | 5 years | |
Noah Knauf | M | 44 | 1 years | |
Avtar Dhillon | M | 62 | 7 years | |
Alexander Casdin | M | 56 | 1 years | |
Don B. Rix | M | 93 | 5 years | |
Jeff Caravella | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 50 | 98.04% |
United States | 1 | 1.96% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rosemina Merchant
- Personal Network